| Literature DB >> 24295983 |
John S Esterly1, Milena M McLaughlin, Michael Malczynski, Chao Qi, Teresa R Zembower, Marc H Scheetz.
Abstract
Clinical studies have suggested that blaOXA-40-positive Acinetobacter baumannii isolates are associated with poor patient outcomes; however, reasons for unfavorable outcomes are difficult to discern in clinical studies. The objective of this study was to assess the virulence of carbapenem-resistant A. baumannii according to blaOXA-40 and epidemiological outbreak status in a Galleria mellonella model. Eight isolates of A. baumannii were studied. Nonoutbreak isolates and blaOXA-40-negative isolates more rapidly killed infected G. mellonella (P < 0.01).Entities:
Mesh:
Substances:
Year: 2013 PMID: 24295983 PMCID: PMC3910851 DOI: 10.1128/AAC.02201-13
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191